Infectious Diseases

Infectious Diseases-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).

Image View List View Download All PDFs Archive

loading
Dosage and administration of non-fucosylated anti-cd40 antibodies
Seattle Genetics, Inc.
May 18, 2017 - N°20170137528

This invention relates methods of using a non-fucosylated anti-cd40 antibody for treatment of cancer and chronic infectious diseases.
Bacteriophage and antibacterial composition comprising the same
Cj Cheiljedang Corporation
May 11, 2017 - N°20170128504

The present invention relates to a novel bacteriophage having a specific bactericidal activity against salmonella, a composition for the prevention or treatment of infectious diseases comprising the bacteriophage as an active ingredient, an antibiotic comprising the bacteriophage as an active ingredient, an animal feed or drinking water comprising the bacteriophage as an active ingredient, and a sanitizer or cleaner comprising ...
System and method for preventing transfer of infectious disease
Cj Cheiljedang Corporation
May 04, 2017 - N°20170124850

A system and method to assist in the prevention of the transfer of infectious diseases. More particularly, a system and method that monitors and alerts caregivers to cleanse, sanitize, and/or wash their hands prior to engaging with other individuals in their care. The disclosed technology includes beacons in wireless communication with a mobile computing device, such as a smart ...
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
Cj Cheiljedang Corporation
May 04, 2017 - N°20170119770

And salts thereof in which r1, r2, r3, r4, x, y and n have the meanings given in the specification, are inhibitors of trk kinases and are useful in the treatment of diseases which can be treated with a trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
Cj Cheiljedang Corporation
April 27, 2017 - N°20170114069

And salts thereof in which r1, r2, r3, r4, x, y and n have the meanings given in the specification, are inhibitors of trk kinases and are useful in the treatment of diseases which can be treated with a trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Macrocyclic compounds as trk kinase inhibitors
Array Biopharma, Inc.
April 27, 2017 - N°20170114059

Compounds of formula i: and pharmaceutically acceptable salts thereof, wherein ring a, ring b, w, m, d, r2, r2a, r3, r3a, and z are as defined herein, are inhibitors of trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Macrocyclic compounds as trk kinase inhibitors
Array Biopharma, Inc.
April 27, 2017 - N°20170112842

Compounds of formula i: and pharmaceutically acceptable salts thereof, wherein ring a, ring b, w, m, d, r2, r2a, r3, r3a, and z are as defined herein, are inhibitors of trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Methods for detecting a biomarker by alternating current electrokinetics
University Of Tennessee Research Foundation
April 20, 2017 - N°20170108493

Methods are described for detecting pathogens, infectious diseases, and physiological conditions by quantifying change of impedance over time of when a biological sample is applied onto a lab-on-a-chip. The lab-on-a-chip utilizes alternating-current electrokinetic (acek) phenomena such that molecules move or are carried in an electric field generated by the application of an electrical signal of predetermined magnitude and frequency to ...
Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious ...
National University Of Singapore
April 20, 2017 - N°20170107491

The invention provides a chimeric receptor comprising nkg2d, dap10 and cd3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of nk cells. The invention also encompansses methods for use of nkg2d-dap10-cd3 zeta polypeptides, vectors and cells in methods for treating cancer ...
Macrocyclic compounds as trk kinase inhibitors
Array Biopharma, Inc.
April 20, 2017 - N°20170107232

Compounds of formula i: and pharmaceutically acceptable salts thereof, wherein ring a, ring b, w, m, d, r2, r2a r3 and r3a are as defined herein, are inhibitors of trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Compounds useful as immunomodulators
Bristol-myers Squibb Company
April 20, 2017 - N°20170107202

The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
University Of Connecticut Health Center
April 13, 2017 - N°20170100455

The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (hsp) preparation or an α-2-macroglobulin (α2m) preparation with a non-vaccine treatment modality. In particular, an hsp preparation or an α2m preparation is administered in conjunction with a non-vaccine treatment modality for the treatment of cancer or ...
Pharmaceutical compositions comprising danirixin for treating infectious diseases
Glaxosmithkline Intellectual Property (no. 2) Limited
April 13, 2017 - N°20170100385

Provided are compounds and pharmaceutically acceptable salts thereof, and combinations of compounds, their pharmaceutical compositions, their methods of preparation, and methods for their use in treating or preventing infectious disease.
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Replication-competent vsv-hiv env vaccines
International Aids Vaccine Initiative
April 06, 2017 - N°20170095551

The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of aids. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
Monoclonal antibodies to programmed death 1 (pd-1)
Ono Pharmaceutical Co., Ltd.
March 30, 2017 - N°20170088615

The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to pd-1 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The ...
Inhibitors of lpxc
The Regents Of The University Of California
March 30, 2017 - N°20170088532

Provided herein, inter alia, are compounds and methods for treating infectious diseases. The compounds provided herein are, inter alia, useful for the treatment of bacterial infections. The compounds provided herein are, inter alia, useful inhibitors of metalloproteins, e. G. Udp-3-o—(r-3-hydroxymyristoyl)-n-acetylglucosamine deacetylase (lpxc).
Modular antigen transportation molecules and uses thereof in animals
Boehringer Ingelheim Vetmedica Gmbh
March 30, 2017 - N°20170087246

The present invention relates to (isolated) recombinant proteins, also referred to as improved mat (imat) molecules, comprising at least one translocation module, at least one targeting module and at least one antigen module, wherein at least one cysteine residue is substituted with a different amino acid residue. Such imat molecules are useful specifically as vaccines, e. G. For therapy and/...
1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2...
Array Biopharma Inc.
March 30, 2017 - N°20170087156

Provided is compound (i) or a pharmaceutically acceptable salt thereof, which is an inhibitor of trka kinase and is useful in the treatment of diseases which can be treated with a trka kinase inhibitor such as pain, cancer, inflammation and inflammatory diseases, neurodegenerative diseases, certain infectious diseases, sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis, pelvic pain syndrome, diseases related to ...
Novel compounds
Array Biopharma Inc.
March 23, 2017 - N°20170080085

Wherein r1 is n-c4-6alkyl or c1-2alkoxyc1-2alkyl-; r2 is hydrogen or methyl; each r3 is hydroxy, halo or n-c1-3alkyl; m is an integer having a value of 2 to 4; n is an integer having a value of 0 to 3; and p is an integer having a value of 0 to 2, are inducers of human interferon. Compounds ...
Female urinary barrier system
Array Biopharma Inc.
March 23, 2017 - N°20170079832

A female urinary barrier system product that includes an exterior vaginal attachment pad for providing a female-user with means to prevent the spread of infectious diseases into their vaginal opening and urinary tract. The product provides a female-user a hand depressible attachment pad useful for enclosing/covering the vagina prior to a bowel movement or just prior to wiping. The ...
Methods for diagnosing infectious diseases using adsorption media
Exthera Medical Corporation
March 16, 2017 - N°20170073727

The present invention provides an in vitro method for concentrating infectious pathogens found in a biological sample obtained from an individual who is suspected of being infected with the pathogens. Provided herein is also an in vitro method for reducing or eliminating blood cells from a sample obtained from an individual suspected to being infected with an infectious pathogen. The ...